Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $1.8 million.

  • Nephros' Cost of Revenue rose 3506.21% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year increase of 2490.05%. This contributed to the annual value of $5.4 million for FY2024, which is 675.47% down from last year.
  • Nephros' Cost of Revenue amounted to $1.8 million in Q3 2025, which was up 3506.21% from $1.6 million recorded in Q2 2025.
  • Nephros' 5-year Cost of Revenue high stood at $1.8 million for Q3 2025, and its period low was $991000.0 during Q2 2021.
  • In the last 5 years, Nephros' Cost of Revenue had a median value of $1.4 million in 2024 and averaged $1.4 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first skyrocketed by 4682.14% in 2022, then crashed by 1582.6% in 2024.
  • Quarter analysis of 5 years shows Nephros' Cost of Revenue stood at $1.2 million in 2021, then decreased by 15.54% to $1.0 million in 2022, then rose by 17.54% to $1.2 million in 2023, then increased by 13.14% to $1.4 million in 2024, then surged by 32.54% to $1.8 million in 2025.
  • Its last three reported values are $1.8 million in Q3 2025, $1.6 million for Q2 2025, and $1.7 million during Q1 2025.